Oramed Pharmaceuticals
ORMP
ORMP
116 hedge funds and large institutions have $122M invested in Oramed Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 44 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
5.87% more ownership
Funds ownership: 16.65% → 22.52% (+5.9%)
3% more capital invested
Capital invested by funds: $119M → $122M (+$3.34M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
116
Holding in Top 10
–
Calls
$5.67M
Puts
$2.52M
Top Buyers
| 1 | +$9.89M | |
| 2 | +$7.36M | |
| 3 | +$5.74M | |
| 4 |
Morgan Stanley
New York
|
+$3.81M |
| 5 |
Two Sigma Advisers
New York
|
+$3.25M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$2.64M | |
| 3 | -$1.46M | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$887K |
| 5 |
Man Group
London,
United Kingdom
|
-$820K |